Project Details
| Status | Active |
|---|---|
| Effective start/end date | 01.07.2020 → 31.12.2025 |
Fields of science
- 302 Clinical Medicine
- 302035 Paediatrics and adolescent medicine
ACcomplisH: A Phase 2, multicenter, double-blind, randomized, placebo-controlled, dose escalation trial evaluating safety, efficacy, and pharmacokinetics of subcutaneous doses of TransCon CNP administered once weekly for 12 months in prepubertal children with achondroplasia
- Hörtenhuber, Thomas (Researcher)
- Montero-Lopez, Rodrigo (Researcher)
- Tischlinger, Katharina (Researcher)
- Högler, Wolfgang (PI)
Project: Clinical studies › Clinical Study (Industry project)